Abiopharma

🔍 Cieri Michael (Executive)

Company: BILL Holdings, Inc. (BILL)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 19,590 shares of Performance Stock Units (Derivative)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,590.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Audit Committee of the Issuer's Board of Directors on August 17, 2026.
• F2: Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
• F3: The PSUs vest and settle over three years; 1/3rd vests on August 28, 2026, and thereafter the remaining 2/3rd will vest quarterly over two years, subject to the continuing service of the Reporting Person on each vesting date.